The Validation study of Adjuvant Online using Iranian breast cancer data

AuthorKhosro Mojir Sheibanien
AuthorKambiz Novinen
AuthorMorteza Tabatabaeefaren
AuthorPayam Azadehen
AuthorAhmad R Mafien
AuthorShiva Moghadamen
AuthorFarnaz Hoseini Kamalen
AuthorAli Ghanbari Motlaghen
Issued Date2013-12-01en
AbstractBackground: Adjuvant Online! (AOL) is used extensively by oncologists in Iran to treat patients with breast cancer; however, it has never been validated for use in Iran, and its predictions might not be applicable to Iranian patients. The aim of this study was to evaluate the usefulness of this program in predicting the outcomes of Iranian patients with breast cancer.en
DOIhttps://doi.org/en
KeywordBreast canceren
KeywordAdjuvant Onlineen
KeywordIranian patientsen
PublisherBrieflandsen
TitleThe Validation study of Adjuvant Online using Iranian breast cancer dataen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
6367-25896-1-PB.pdf
Size:
473.13 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF